
Thromboembolic complications related to SARS-CoV-2 have been extensively reported. They include deep vein thrombosis, pulmonary embolism, ischemic stroke, and acute coronary syndrome. Penile thrombosis has not been reported as a thrombotic complication of SARS-CoV-2 infection with hypercoagulability. Here we describe a case of priapism as a thromboembolic complication in a patient with COVID-19 who recovered from acute respiratory distress syndrome (ARDS). We discuss the underlying pathophysiological mechanisms mainly related to an hypercoagulability state. Emergency management consisted on an intracavernosal injection of the sympathomimetic agent ethylephrine and cavernosal blood aspiration. The patient experienced no recurrences under thromboprophylaxis by enoxaparin 40 mg twice daily.
Male, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Anticoagulants, COVID-19, Case Report, Thrombosis, General Medicine, Middle Aged, Emergency Medicine, Humans, Enoxaparin, Priapism, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Male, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Anticoagulants, COVID-19, Case Report, Thrombosis, General Medicine, Middle Aged, Emergency Medicine, Humans, Enoxaparin, Priapism, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 34 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
